Emily Mullin is a staff writer at Wired.
Segment
Listen
China’s booming biotech, from a brain implant to drug discovery
China’s biotech industry is on a rapid rise, with the first approved brain-computer interface and massive growth in drug discovery.
Segment
Listen
4:36
FDA Is Back On Board With A Breast Cancer Test
The FDA will now allow the consumer genetic testing company 23andMe to screen customers for mutations that boost breast cancer risk.